• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pacira Pharmaceuticals Inc/DE

+ Add to Watchlist

PCRX:US

94.4700 USD 0.5300 0.56%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Pacira Pharmaceuticals Inc/DE (PCRX)

Open: 93.3900 Day's Range: 92.4900 - 94.8600 Volume: 771,556
Previous Close: 93.9400 52wk Range: 50.0000 - 111.9970 1-Yr Rtn: +90.12%

Stock Chart for PCRX

No chart data available.
  • PCRX:US 94.4700
  • 1D
  • 1M
  • 1Y
93.9400
Interactive PCRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PCRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 505.1872
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.9200
Est. EPS (USD) (12/2014) 0.1870
Est. PEG Ratio -
Market Cap (M USD) 3,406.18
Shares Outstanding (M) 36.06
30 Day Average Volume 440,385
Price/Book (mrq) 21.9445
Price/Sale (ttm) 19.4173
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PCRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PCRX

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company with focuses on the development, commercialization, and manufacturing of proprietary pharmaceutical products. The Company's products are used in hospitals and ambulatory surgery centers.

David M Stack "Dave"Chairman/President/CEOJames S ScibettaSenior VP/CFO
Taunia MarkvickaSenior VP/Chief Commercial OfcrLauren RikerExec Dir:Finance
More Company Profile & Key Executives for PCRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil